Trillium Renewable Chemicals Secures $13M Series B Funding Led by HS Hyosung Advanced Materials

Why It Matters

A low‑carbon acrylonitrile can dramatically reduce the embedded emissions of countless downstream products, giving manufacturers a practical pathway to meet tightening Scope 3 targets. Trillium’s commercial‑ready technology signals a scalable route to decarbonize a core petrochemical feedstock.

Key Takeaways

• Trillium raised $13 million Series B led by HS Hyosung.
• First demo plant for bio‑based acrylonitrile completed in Texas.
• Proprietary catalyst converts glycerol to acrylonitrile in two steps.
• Product is a drop‑in replacement for fossil‑derived acrylonitrile.
• Customers show interest despite potential green‑premium pricing.

Pulse Analysis

The global chemicals sector is responsible for roughly 5 % of total greenhouse‑gas emissions, and a large share of that footprint originates from the production of basic intermediates. Acrylonitrile, a cornerstone monomer for carbon‑fiber composites, synthetic rubber, and plastics such as LEGO bricks, is traditionally derived from propylene, a petroleum by‑product. Because the monomer’s energy‑intensive synthesis dominates the lifecycle emissions of downstream products, a low‑carbon alternative can slash the embedded carbon of countless end‑uses without redesigning the final product.

Trillium Renewable Chemicals, a spin‑out of the DOE‑funded Southern Research Institute, has turned that chemistry into a commercial proposition. The company secured a $13 million Series B round, led by HS Hyosung Advanced Materials, to fund the commissioning of the world’s first demonstration plant in Texas. A proprietary catalyst and a two‑step thermochemical pathway convert glycerol—a low‑cost, bio‑derived feedstock—into acrylonitrile, delivering a drop‑in material that fits existing supply chains. The funding also backs engineering work for a full‑scale facility, underscoring the startup’s risk‑tolerant, commercialization‑first mindset.

The market implication is clear: customers seeking to decarbonize high‑value products now have a viable, drop‑in option, even if it carries a modest green premium. Early adopters in aerospace, automotive and medical‑device sectors are already signaling willingness to pay for lower‑carbon acrylonitrile, a trend that could accelerate as regulatory pressure on Scope 3 emissions intensifies. If Trillium can scale to commercial volumes and achieve cost parity, it would set a precedent for bio‑based replacements of other petrochemical building blocks, reshaping the supply chain toward a more sustainable chemistry ecosystem. Such a shift would also stimulate investment in green catalyst research across the industry.

Deal Summary

Trillium Renewable Chemicals announced a $13 million Series B round led by HS Hyosung Advanced Materials to scale its bio‑based acrylonitrile production. The funding will support commissioning a demonstration plant in Texas and the design of its first commercial facility. The round highlights investor interest in low‑carbon chemical solutions.